Art

J-GLOBAL ID：201702256236017405   Reference number：17A0681904

Importance of Professional Oral Hygiene in Preventing Medication-related Osteonecrosis of the Jaw

顎の服薬と関係した骨壊死を防止する専門的な口腔衛生の重要性

Author (6)： Ohnishi Yoshimi (Division of Dysphagia Rehabilitation, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata 951-8514, Japan) ,  Ito Kayoko (Oral Rehabilitation, Niigata University Medical and Dental Hospital, Niigata, Niigata 951-8520, Japan) ,  Kitamura Ryuji (Department of Dentistry, Oral and Maxillofacial Surgery, Kansai Rosai Hospital, Amagasaki, hyougo 660-8511, Japan) ,  Funayama Saori (Oral Rehabilitation, Niigata University Medical and Dental Hospital, Niigata, Niigata 951-8520, Japan) ,  Hori Kazuhiro (Division of Comprehensive Prosthodontics, Niigata University Graduate School of Medical and Dental Sciences, Niigata,Niigata 951-8514, Japan) ,  Inoue Makoto (Division of Dysphagia Rehabilitation, Niigata University Graduate School of Medical and Dental Sciences, Niigata, Niigata 951-8514, Japan)
Material： International Journal of Oral-Medical Sciences  (IJOMS)
Volume： 15  Issue： 3-4  Page： 85-92(J-STAGE)  Publication year： 2017 
JST Material Number： L4836A  ISSN： 1347-9733  Document type： Article
Article type： 原著論文  Country of issue： Japan (JPN)  Language： ENGLISH (EN)

Thesaurus term： *necrosis ,...
Semi thesaurus term： *osteonecrosis of jaw ,...

Register(free) or Log In to access     To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=17A0681904&from=J-GLOBAL&jstjournalNo=L4836A") }}

Author keywords (4)： bisphosphonate ,  MRONJ ,  oral hygiene ,  risk factor

JST classification (3)： Oral hygiene  (GT07000I) ,  Clinical medicine on musculoskeletal system in general  (GG01030M) ,  Clinical application of other drugs acting on metabolism  (GW13070T)

Substance index (1)： Zoledronate

Reference (21)：

• 1. American Association of Oral and Maxillofacial Surgeons position paper on bisphosphonate-related osteonecrosis of the jaws. J Oral Maxillofac Surg, 65: 369-376, 2007.
• 2. Ruggiero S, Dodson T, Fantasia J, Goodday R, Aghaloo T, Mehrotra B, O'Ryan F: American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw-2014 update. J Oral Maxillofac Surg,72: 1938-1956, 2014.
• 3. Marx RE: Pamidronate (Aredia) and zoledronate (Zometa) induced avascular necrosis of the jaws: a growing epidemic. J Oral Maxillofac Surg, 61: 1115-1117, 2003.
• 4. Mavrokokki T, Cheng A, Stein B, Goss A: Nature and frequency of bisphosphonate-associated osteonecrosis of the jaws in Australia. J Oral Maxillofac Surg, 65: 415-423, 2007.
• 5. McCauley LK, Li X: Distinguishing features of the oral cavity and its predisposition to osteonecrosis. J Musculoskelet Neuronal Interact, 7: 356-357, 2007.

Terms in the title (5)： 顎 ,  服薬 ,  骨壊死 ,  口腔衛生 ,  重要性